Delivery Order SPE2DB22D2214-SPE2DB25FS5VB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,152.10 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine procurement action supporting...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of $5,107.64 worth of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccines. This delivery order has a completion date of February 29, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which was not set aside under any specific program. Additionally, AmerisourceBergen Drug Corp holds an...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $9,182.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for a Menveo A-C-Y-W Kit (2 vials) on July 18, 2025. The order, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside contract with performance occurring at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This $229,017.14 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,564,708,672 units of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with a performance period through May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a $167,224.78 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a period of performance through July 1, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of a pharmaceutical product, specifically Menveo, a meningococcal ACYW-135 conjugate vaccine, in a quantity of 1 vial. The potential value of this order is $1,428.70, with a completion date of February 1, 2024. Amerisourcebergen Drug Corp, based in Conshohocken, Pennsylvania, is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,918.60 firm fixed-price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The delivery order has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Menveo 1 vial-A-C-Y-W-135-DIP 0.5ML vaccines. The $5,483.75 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with a larger contract vehicle. No set-aside designation was used for this award....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,274,341 units of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The $18,265.50 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under a larger $999,999,999.00...
- This is a $2,164.13 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5 mL MENVEO 1 VIAL-A-C-Y-W-135-DIP vaccines, with a completion date of July 10, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5VBDelivery Order
The Defense Logistics Agency awarded a $157,016.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine product, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and related entities. The company was competitively selected through open procurement and has demonstrated capability in fulfilling diverse federal medical supply needs across therapeutic domains. This delivery order for Menveo vaccines aligns with DLA's mission to provide medical supplies and pharmaceuticals to support military personnel and healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $157.0k | 7/18/25 |